Lycera and Merck & Co. to Develop Autoimmune Disease Drugs Targeting Th17 Cells
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 3 (Table of Contents)
Published: 21 Mar-2011
DOI: 10.3833/pdr.v2011.i3.1447 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Lycera has partnered with Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS